KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 5 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $3 | +50.0% | 139 | 0.0% | 0.00% | – |
Q4 2023 | $2 | 0.0% | 139 | 0.0% | 0.00% | – |
Q3 2023 | $2 | 0.0% | 139 | 0.0% | 0.00% | – |
Q2 2023 | $2 | +100.0% | 139 | 0.0% | 0.00% | – |
Q1 2023 | $1 | -50.0% | 139 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.8% | 139 | +131.7% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 60 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 60 | -48.7% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 117 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 117 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | – | 117 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |